**Median Technologies Obtains FDA Clearance for eyonis® LCS Lung Cancer Screening Device**
Median Technologies announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its eyonis® LCS device. This technology uses artificial intelligence to assist in the detection and diagnosis of lung cancer during screening. The eyonis® LCS system is designed to improve the accuracy and efficiency of …